The growing concern of patient non-compliance and poor adherence to conventional medication regimen has prompted various biopharmaceutical companies to leverage the expertise of players offering long-acting drug delivery technologies and services
Roots Analysis is pleased to announce the publication of its recent study, titled, “Long-Acting Drug Delivery Market, 2023-2035”
The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report includes
- An executive summary of the insights captured during our research. It offers a high-level view on the current state of long acting drugs delivery technologies and services market and its likely evolution in the mid-long term.
- A general overview of long-acting drug delivery and the different types of long-acting drug delivery systems. Additionally, it highlights the underlying principles and strategies associated with long-acting drug delivery.
- A detailed assessment of the current technology landscape of long-acting drug delivery technologies.
- A detailed assessment of the overall service providers landscape of the companies offering contract services related to long-acting drug delivery.
- A technology competitiveness analysis of long-acting drug delivery technologies.
- A company competitiveness analysis of long-acting drug delivery service providers.
- Elaborate profiles of prominent players developing technologies and offering services in the domain of long-acting drug delivery (shortlisted based on a proprietary criterion).
- A detailed analysis of the recent partnerships inked between stakeholders engaged in this domain, since 2018.
- A detailed analysis of over 570 peer-reviewed, scientific articles focused on research related to long-acting drug delivery.
- An in-depth analysis of various patents that have been filed / granted related to long-acting drug delivery, since 2018.
- A detailed review of academic grants that have been awarded to various research institutes for projects focused on long-acting drug delivery, since 2018.
- A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
- Principle
- Manipulation of drug release from delivery systems
- Manipulation of in vivo clearance
- Strategy
- Chemical Modification
- Micro-encapsulation
- Long-Acting Hydrogels
- Long-Acting Implants
- Long-Acting Microneedles
- Multivesicular Liposomes
- Nanocrystal Suspensions
- Protein Fusion
- Compatible Dosage Form
- Injectables
- Implantables
- Oral Dosage Forms
- Topical / Transdermal Dosage Forms
- Vaginal Dosage Forms
- Other Dosage Forms
- Type of Molecules Delivered
- Small Molecules
- Biologics
- Other Molecules
- Type of Material Used
- Polymer based
- Non-polymer based
- Key Geographical Regions
- North America
- Europe
- Asia-Pacific
- Middle East and North Africa
Key companies covered in the report
- Adare Pharma Solutions
- AMW
- Bostal Drug Delivery
- Creative Biolabs
- ForDoz Pharma
- Innocore Pharmaceuticals
- Integral BioSystems
- LATITUDE Pharmaceuticals
- Navin Saxena Research and Technology Centre (NSRT)
- Samyang Biopharm
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/long-acting-drug-delivery-market.html
You may also be interested in the following titles:
|
Oral Solid Dosage Manufacturing Market |
|
Lipid Nanoparticles in Drug Delivery Bioavailability enhancement services market Global Gene Switch Market |
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
